Table 3.
Results of ordinal logistic regressions with taking and timing adherence scores as outcomes – Odds ratio associated with covariates in multivariate models (run-in period of the TAKE-IT trial, n=136)
| Taking adherence | Timing adherence | |
|---|---|---|
| Odds ratio (95%CI) | Odds ratio (95%CI) | |
| Demographics | ||
| Race | ||
| White (ref.) | - | - |
| Black | 0.48 (0.28–0.85) | 0.51 (0.31–0.84) |
| Other | 0.82 (0.47–1.42) | 0.96 (0.59–1.56) |
| Healthcare insurer | ||
| U.S. Public (ref.) | - | - |
| U.S. Private | 0.91 (0.55–1.49) | 0.99 (0.65–1.50) |
| Canadian provincial | 1.23 (0.66–2.27) | 1.34 (0.80–2.25) |
| Disease characteristics | ||
| Duration of dialysis before current transplant | ||
| 0 month | 1.71 (1.09–2.66) | 1.80 (1.21–2.68) |
| > 0 month (ref.) | - | - |
| Primary disease | ||
| CAKUT (ref.) | - | - |
| Glomerulonephritis | 1.96 (0.97–3.99) | 1.28 (0.69–2.38) |
| FSGS | 0.67 (0.38–1.16) | 0.69 (0.42–1.15) |
| Other | 1.04 (0.59–1.84) | 0.99 (0.61–1.61) |
| Treatment characteristics | ||
| Number of immunosuppressive medications | ||
| 1 | 1.83 (0.79–4.25) | 1.34 (0.35–5.15) |
| 2 | 0.84 (0.53–1.31) | 0.82 (0.55–1.22) |
| 3 (ref.) | - | - |
An OR < 1 means that odds of higher taking or timing adherence scores are lower for the compared group compared to the reference.